RadNet, Inc.
RDNT
Κατάταξη σε μετοχές
#3213
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Τιμή μετοχής
$70.74
Κεφαλαιοποίηση
$5.57B
Αλλαγή (1 ημέρα)
2.13%
Αλλαγή (1 έτος)
-9.81%
Χώρα
US
Εμπόριο RadNet, Inc. (RDNT)
Κατηγορία
Healthcare
Κέρδη για την RadNet, Inc. (RDNT)
Κέρδη τον Jun 2026 TTM: $34.98M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της RadNet, Inc., τα τρέχοντα κέρδη της εταιρείας είναι $34.98M. Το 2023, η εταιρεία παρουσίασε κέρδη $38.81M, μείωση σε σύγκριση με των κερδών του 2022 που ήταν $42.97M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την RadNet, Inc. από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $34.98M | -22.03% |
| 2024 | $44.86M | 15.59% |
| 2023 | $38.81M | -9.68% |
| 2022 | $42.97M | -27.02% |
| 2021 | $58.88M | -6,994.50% |
| 2020 | $-854.00K | -102.88% |
| 2019 | $29.67M | -22.99% |
| 2018 | $38.53M | 46.02% |
| 2017 | $26.39M | 112.17% |
| 2016 | $12.44M | -15.08% |
| 2015 | $14.65M | 301.01% |
| 2014 | $3.65M | -37.95% |
| 2013 | $5.89M | -380.42% |
| 2012 | $-2.10M | -171.44% |
| 2011 | $2.94M | -114.45% |
| 2010 | $-20.34M | 99.64% |
| 2009 | $-10.19M | -46.58% |
| 2008 | $-19.07M | 5.18% |
| 2007 | $-18.13M | 163.00% |
| 2006 | $-6.89M | 119.90% |
| 2005 | $-3.14M | -66.44% |
| 2004 | $-9.34M | 74.17% |
| 2003 | $-5.36M | 3.83% |
| 2002 | $-5.17M | -156.26% |
| 2001 | $9.18M | -36.69% |
| 2000 | $14.50M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $7.61B | 21,653.05% |
US
|
|
| $4.76B | 13,513.88% |
US
|
|
| $-252.70M | -822.44% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 4,639.99% |
US
|
